ID   UBP15_BOVIN             Reviewed;         952 AA.
AC   Q2HJE4;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 1.
DT   10-FEB-2021, entry version 111.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 15;
DE            EC=3.4.19.12 {ECO:0000250|UniProtKB:Q9Y4E8};
DE   AltName: Full=Deubiquitinating enzyme 15;
DE   AltName: Full=Ubiquitin thioesterase 15;
DE   AltName: Full=Ubiquitin-specific-processing protease 15;
GN   Name=USP15;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Hereford;
RX   PubMed=19393038; DOI=10.1186/gb-2009-10-4-r42;
RA   Zimin A.V., Delcher A.L., Florea L., Kelley D.R., Schatz M.C., Puiu D.,
RA   Hanrahan F., Pertea G., Van Tassell C.P., Sonstegard T.S., Marcais G.,
RA   Roberts M., Subramanian P., Yorke J.A., Salzberg S.L.;
RT   "A whole-genome assembly of the domestic cow, Bos taurus.";
RL   Genome Biol. 10:R42.01-R42.10(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Uterus;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Hydrolase that removes conjugated ubiquitin from target
CC       proteins and regulates various pathways such as the TGF-beta receptor
CC       signaling, NF-kappa-B and RNF41/NRDP1-PRKN pathways. Acts as a key
CC       regulator of TGF-beta receptor signaling pathway, but the precise
CC       mechanism is still unclear: according to a report, acts by promoting
CC       deubiquitination of monoubiquitinated R-SMADs (SMAD1, SMAD2 and/or
CC       SMAD3), thereby alleviating inhibition of R-SMADs and promoting
CC       activation of TGF-beta target genes. According to another reports,
CC       regulates the TGF-beta receptor signaling pathway by mediating
CC       deubiquitination and stabilization of TGFBR1, leading to an enhanced
CC       TGF-beta signal. Able to mediate deubiquitination of monoubiquitinated
CC       substrates as well as 'Lys-48'-linked polyubiquitin chains, protecting
CC       them against proteasomal degradation. May also regulate gene expression
CC       and/or DNA repair through the deubiquitination of histone H2B. Acts as
CC       an inhibitor of mitophagy by counteracting the action of parkin (PRKN):
CC       hydrolyzes cleavage of 'Lys-48'- and 'Lys-63'-linked polyubiquitin
CC       chains attached by parkin on target proteins such as MFN2, thereby
CC       reducing parkin's ability to drive mitophagy. Acts as an associated
CC       component of COP9 signalosome complex (CSN) and regulates different
CC       pathways via this association: regulates NF-kappa-B by mediating
CC       deubiquitination of NFKBIA and deubiquitinates substrates bound to VCP.
CC       Involved in endosome organization by mediating deubiquitination of
CC       SQSTM1: ubiquitinated SQSTM1 forms a molecular bridge that restrains
CC       cognate vesicles in the perinuclear region and its deubiquitination
CC       releases target vesicles for fast transport into the cell periphery.
CC       {ECO:0000250|UniProtKB:Q9Y4E8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000250|UniProtKB:Q9Y4E8};
CC   -!- SUBUNIT: A homodimer structure has been reported; however it is unclear
CC       whether the protein form a homodimer in vivo. Identified in a complex
CC       with the COP9 signalosome complex (CSN). Interacts with SMAD1, SMAD2
CC       and SMAD3; the interaction is direct. Forms a complex with SMURF2 and
CC       SMAD7. Interacts with TGFBR1. Interacts with SART3; the interaction is
CC       direct. May interact with RNF20 and RNF40. May interact with PRKN.
CC       Interacts with INCA1. {ECO:0000250|UniProtKB:Q9Y4E8}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9Y4E8}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9Y4E8}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q9Y4E8}.
CC   -!- PTM: Phosphorylated. Phosphorylation protects against ubiquitination
CC       and subsequent degradation by the proteasome.
CC       {ECO:0000250|UniProtKB:Q9Y4E8}.
CC   -!- PTM: Ubiquitinated, leading to degradation by the proteasome.
CC       {ECO:0000250|UniProtKB:Q9Y4E8}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DAAA02013374; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; DAAA02013375; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; DAAA02013376; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; DAAA02013377; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; DAAA02013378; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC105521; AAI05522.1; -; mRNA.
DR   RefSeq; NP_001039895.1; NM_001046430.2.
DR   BMRB; Q2HJE4; -.
DR   SMR; Q2HJE4; -.
DR   STRING; 9913.ENSBTAP00000037402; -.
DR   MEROPS; C19.022; -.
DR   PaxDb; Q2HJE4; -.
DR   PRIDE; Q2HJE4; -.
DR   Ensembl; ENSBTAT00000078328; ENSBTAP00000056662; ENSBTAG00000010428.
DR   GeneID; 538284; -.
DR   KEGG; bta:538284; -.
DR   CTD; 9958; -.
DR   VGNC; VGNC:36713; USP15.
DR   eggNOG; KOG1870; Eukaryota.
DR   GeneTree; ENSGT00940000154932; -.
DR   HOGENOM; CLU_001060_7_1_1; -.
DR   InParanoid; Q2HJE4; -.
DR   OMA; ELPCHAQ; -.
DR   OrthoDB; 1283205at2759; -.
DR   TreeFam; TF106276; -.
DR   Proteomes; UP000009136; Chromosome 5.
DR   Proteomes; UP000321980; Unassembled WGS sequence.
DR   Bgee; ENSBTAG00000010428; Expressed in spermatid and 19 other tissues.
DR   ExpressionAtlas; Q2HJE4; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; ISS:UniProtKB.
DR   GO; GO:0030509; P:BMP signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035616; P:histone H2B conserved C-terminal lysine deubiquitination; ISS:UniProtKB.
DR   GO; GO:0035520; P:monoubiquitinated protein deubiquitination; ISS:UniProtKB.
DR   GO; GO:0060389; P:pathway-restricted SMAD protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; ISS:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR035927; DUSP-like_sf.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR006615; Pept_C19_DUSP.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR013792; RNA3'P_cycl/enolpyr_Trfase_a/b.
DR   InterPro; IPR028135; Ub_USP-typ.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR029346; USP_C.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF06337; DUSP; 1.
DR   Pfam; PF14836; Ubiquitin_3; 1.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF14533; USP7_C2; 1.
DR   SMART; SM00695; DUSP; 1.
DR   SUPFAM; SSF143791; SSF143791; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF55205; SSF55205; 1.
DR   PROSITE; PS51283; DUSP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Cytoplasm; Hydrolase; Mitochondrion; Nucleus; Phosphoprotein;
KW   Protease; Reference proteome; Thiol protease; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4E8"
FT   CHAIN           2..952
FT                   /note="Ubiquitin carboxyl-terminal hydrolase 15"
FT                   /id="PRO_0000420489"
FT   DOMAIN          7..118
FT                   /note="DUSP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00613"
FT   DOMAIN          260..904
FT                   /note="USP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01035"
FT   REGION          2..223
FT                   /note="Mediates interaction with SART3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4E8"
FT   ACT_SITE        269
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092,
FT                   ECO:0000255|PROSITE-ProRule:PRU10093"
FT   ACT_SITE        862
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092,
FT                   ECO:0000255|PROSITE-ProRule:PRU10093"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4E8"
FT   MOD_RES         226
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4E8"
FT   MOD_RES         573
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R5H1"
FT   MOD_RES         932
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4E8"
FT   MOD_RES         936
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4E8"
SQ   SEQUENCE   952 AA;  109442 MW;  A4151AAE16BE8B53 CRC64;
     MAEGGAADLD IQRSDIATLL KTSLRKGDTW YLVDSRWFKQ WKKYVGFDSW DKYQMGDQNV
     YPGPIDNSGL LRDGDAQSLK EHLIDELDYI LLPTEGWNKL VSWYTLMEGQ EPIARKVVEQ
     GMFVKHCKVE VYLTELKLCE NGNMNNVVTR RFSKADTIDT IEKEIRKIFN IPDEKETRLW
     NKYMSNTFEP LNKPDSTIQD AGLYQGQVLV IEQKNEDGTW PRGPSTPNVK NSNYCLPSYT
     AYKNYDYSEP GRNNEQPGLC GLSNLGNTCF MNSAFQCLSN TPPLTEYFLN DKYQEELNFD
     NPLGMRGEIA KSYAELIKQM WSGKYSYVTP RAFKTQVGRF APQFSGYQQQ DCQELLAFLL
     DGLHEDLNRI RKKPYIQLKD ADGRPDKVVA EEAWENHLKR NDSIIVDIFH GLFKSTLVCP
     ECAKISVTFD PFCYLTLPLP MKKERTLEVY LVRMDPLTKP MQYKVVVPKI GNILDLCTAL
     SLLSGVPADK MIVTDIYNHR FHRIFAMDEN LSSIMERDDI YVFEININRT EDTEHVIIPV
     CLREKFRHSS YTHHTGSSLF GQPFLMAVPR NNTEDKLYNL LLVRMCRYVK ISTDTEDTEG
     SLHCCKDQNI NGNGPNGIHE EGSPSEMETD EPDDESSQDQ ELPSENENSQ SEDSVGGDND
     SENGLCTEET CRGQLTGHKK RLFTFQFNNL GNTDINYIKD DTRHIRFDDR QLRLDERSFL
     ALDWDPDLKK RYFDENAAED FEKHESVEYK PPKKPFVKLK DCIELFTTKE KLGAEDPWYC
     PNCKEHQQAT KKLDLWSLPP VLVVHLKRFS YSRYMRDKLD TLVDFPINDL DMSEFLINPN
     AGPCRYNLIA VSNHYGGMGG GHYTAFAKNK DDGKWYYFDD SSVSTASEDQ IVSKAAYVLF
     YQRQDTFSGT GFFPLDRETK GASAATGIPL ESDEDSNDND NDIENENCMH TN
//
